ARCHIVES

PCORI Approves $54.8 Million For Clinical Effectiveness Research

This article is from The Cancer Letter archive.

Vol. 40 No. 31 | August 1, 2014

Download PDF Visit The Full Archive

Related Articles

Improved NCI Relations With FDA Cited As Model For Government Accord, Lasagna Committee Says

April 20, 1990

Alimta Reduces Risk Of Progression In Patients Aged 70 Years or Older

October 28, 2011

DOD Names Innovator Award Recipients.

April 26, 2002

In Brief: House Cuts NCI Rescission To $7.73 Million; Weinhuse, Ultmann New ACCR, ASCO Presidents

May 8, 1981

Professional Issues: AMA Identifies Tobacco-Free Mutual Funds

February 21, 1997

In Brief: Daniel Ihde Named NCI Deputy Director; Roper Is Carter consultant; Another Honor For Forei

February 8, 1991